Joshua A. Barocas

3.0k total citations · 1 hit paper
99 papers, 1.6k citations indexed

About

Joshua A. Barocas is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and General Health Professions. According to data from OpenAlex, Joshua A. Barocas has authored 99 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Epidemiology, 53 papers in Public Health, Environmental and Occupational Health and 26 papers in General Health Professions. Recurrent topics in Joshua A. Barocas's work include Opioid Use Disorder Treatment (50 papers), HIV, Drug Use, Sexual Risk (34 papers) and Substance Abuse Treatment and Outcomes (24 papers). Joshua A. Barocas is often cited by papers focused on Opioid Use Disorder Treatment (50 papers), HIV, Drug Use, Sexual Risk (34 papers) and Substance Abuse Treatment and Outcomes (24 papers). Joshua A. Barocas collaborates with scholars based in United States, Canada and United Kingdom. Joshua A. Barocas's co-authors include Benjamin P. Linas, Jianing Wang, Jake R. Morgan, Alexander Y. Walley, David Victorson, David Cella, Dana Bernson, Laura F. White, Jeffrey H. Samet and Ryan P. Westergaard and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Joshua A. Barocas

85 papers receiving 1.6k citations

Hit Papers

What is the prevalence of and trend in opioid use disorde... 2022 2026 2023 2024 2022 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size
    2022 135 citations Katherine M. Keyes, Caroline Rutherford et al. SHILAP Revista de lepidopterología profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joshua A. Barocas United States 22 951 868 294 238 207 99 1.6k
Jake R. Morgan United States 20 913 1.0× 844 1.0× 271 0.9× 139 0.6× 200 1.0× 75 1.4k
Huiru Dong Canada 22 1.1k 1.2× 964 1.1× 338 1.1× 309 1.3× 371 1.8× 121 2.0k
Jeong Eun Min Canada 23 1.0k 1.1× 924 1.1× 309 1.1× 552 2.3× 244 1.2× 69 1.7k
Yngvild Olsen United States 21 1.0k 1.1× 1.2k 1.4× 409 1.4× 119 0.5× 269 1.3× 40 1.7k
Barbara Broers Switzerland 19 655 0.7× 310 0.4× 128 0.4× 261 1.1× 192 0.9× 63 1.4k
Margot Kuo Canada 17 692 0.7× 494 0.6× 117 0.4× 140 0.6× 189 0.9× 37 1.1k
Nina Shah United States 24 939 1.0× 687 0.8× 214 0.7× 576 2.4× 407 2.0× 44 2.0k
Aaron D. Fox United States 23 786 0.8× 938 1.1× 249 0.8× 113 0.5× 296 1.4× 68 1.5k
Judith I. Tsui United States 26 1.9k 2.0× 1.1k 1.3× 308 1.0× 402 1.7× 266 1.3× 147 2.7k
María J. Bravo Spain 25 1.9k 2.0× 1.8k 2.0× 496 1.7× 352 1.5× 336 1.6× 77 2.9k

Countries citing papers authored by Joshua A. Barocas

Since Specialization
Citations

This map shows the geographic impact of Joshua A. Barocas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua A. Barocas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua A. Barocas more than expected).

Fields of papers citing papers by Joshua A. Barocas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua A. Barocas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua A. Barocas. The network helps show where Joshua A. Barocas may publish in the future.

Co-authorship network of co-authors of Joshua A. Barocas

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua A. Barocas. A scholar is included among the top collaborators of Joshua A. Barocas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua A. Barocas. Joshua A. Barocas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Tian, Katherine M. Keyes, Shijun Ji, et al.. (2025). Opioid use disorder prevalence in 57 New York counties from 2017 to 2019: A Bayesian evidence synthesis. Drug and Alcohol Dependence. 267. 112548–112548.
2.
Barocas, Joshua A.. (2025). The Erosion of Harm Reduction. New England Journal of Medicine. 393(19). 1865–1867.
3.
González, Karina, et al.. (2025). Risk factors for multiple skin abscesses among community-recruited people who inject drugs in Los Angeles, CA, and Denver, CO: a cross-sectional study. Therapeutic Advances in Infectious Disease. 12. 2038579581–2038579581.
4.
5.
Calcaterra, Susan L., Daniel Ciccarone, Brandon del Pozo, et al.. (2024). NATIONAL TRENDS IN METHAMPHETAMINE-RELATED PSYCHIATRIC HOSPITALIZATIONS IN THE UNITED STATES, 2015-2019. Drug and Alcohol Dependence. 260. 110065–110065.
6.
Goldshear, Jesse L., et al.. (2024). Association of Involuntary Displacement of People Experiencing Homelessness and Crime in Denver, CO: A Spatiotemporal Analysis. Journal of Urban Health. 102(1). 8–18. 2 indexed citations
7.
Bartholomew, Tyler S., Marina Plesons, David P. Serota, et al.. (2024). Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services. Addiction Science & Clinical Practice. 19(1). 21–21. 2 indexed citations
8.
9.
10.
Palis, Heather, et al.. (2023). Rising rates of infective endocarditis in North America: An urgent need for attention to the rapidly changing unregulated drug supply. International Journal of Drug Policy. 118. 104110–104110. 3 indexed citations
11.
Calcaterra, Susan L., Alexandra Savinkina, Laura R. Marks, et al.. (2023). Estimated Clinical Outcomes and Cost-effectiveness Associated With Provision of Addiction Treatment in US Primary Care Clinics. JAMA Network Open. 6(4). e237888–e237888. 7 indexed citations
12.
Barocas, Joshua A., et al.. (2023). Using Evidence to Inform Legislation Aimed at Curbing Fentanyl Deaths. JAMA Health Forum. 4(1). e225202–e225202. 4 indexed citations
13.
Aldridge, Arnie, et al.. (2023). Establishing a Protocol for Determining the Costs of an Integrated Set of Evidence-based Practices Aimed at Reducing Opioid Overdose Deaths. Journal of Addiction Medicine. 18(1). 13–18. 1 indexed citations
14.
Keyes, Katherine M., Caroline Rutherford, Ava Hamilton, et al.. (2022). What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size. SHILAP Revista de lepidopterología. 3. 100052–100052. 135 indexed citations breakdown →
15.
Adams, Joëlla W., Alexandra Savinkina, Aaron D. Fox, et al.. (2022). Modeling the cost‐effectiveness and impact on fatal overdose and initiation of buprenorphine–naloxone treatment at syringe service programs. Addiction. 117(10). 2635–2648. 6 indexed citations
16.
Sinha, Pranay & Joshua A. Barocas. (2022). Cost‐effectiveness of aducanumab to prevent Alzheimer's disease progression at current list price. Alzheimer s & Dementia Translational Research & Clinical Interventions. 8(1). e12256–e12256. 16 indexed citations
17.
Zielinski, Melissa J., et al.. (2022). Crisis stabilization units for jail diversion: A preliminary assessment of patient characteristics and outcomes.. Psychological Services. 19(4). 630–636. 1 indexed citations
18.
19.
Adams, Joëlla W., Alexandra Savinkina, Simeon D. Kimmel, et al.. (2021). 58. Cost-Effectiveness of Emerging Antibiotic Strategies for the Treatment of Drug-Use Associated Infective Endocarditis. Open Forum Infectious Diseases. 8(Supplement_1). S40–S40.
20.
Schranz, Asher J & Joshua A. Barocas. (2020). Infective Endocarditis in Persons Who Use Drugs. Infectious Disease Clinics of North America. 34(3). 479–493. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jake R. Morgan Breakdown of academic impact, for papers by Huiru Dong Breakdown of academic impact, for papers by Jeong Eun Min Breakdown of academic impact, for papers by Yngvild Olsen Breakdown of academic impact, for papers by Barbara Broers Breakdown of academic impact, for papers by Margot Kuo Breakdown of academic impact, for papers by Nina Shah Breakdown of academic impact, for papers by Aaron D. Fox Breakdown of academic impact, for papers by Judith I. Tsui Breakdown of academic impact, for papers by María J. Bravo
Rankless by CCL
2026